Announcement || FDAC Performance Review for CY 2022 And Planning for CY 2023 on 01-03 December 2022, Development Academy of the Philippines (DAP) Tagaytay
Please be informed that the Food and Drug Action Center (FDAC) will be having its Performance Review for CY 2022, Cascading of Quality Work Procedures, Cascading of FDA Citizen’s Charter […]
Announcement || Common Services Laboratory Year-end Program Implementation Review and Cascading of Quality Management System Procedures
The Common Services Laboratory will be having its Year-end Program Implementation Review and Cascading of Quality Management System Procedures on 22 to 24 November 2022. All online transactions, except for […]
Announcement || Final Conduct of Hands-On Workshop with the HUHS Industry
In the interest of service, the Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research (CCHUHSRR), Food and Drug Administration (FDA), has regularly conducted onsite and virtual sessions of […]
NOTICE OF SALE || The Food and Drug Administration (FDA) hereby invites all interested parties to bid for the Public Bidding/Auction/Sale of the following FDA Unserviceable/Obsolete PPE, in cash to the highest bidder.
The Food and Drug Administration (FDA) through its Inventory and Disposal Committee (IDC) hereby invites all interested parties to participate in the Public Bidding/Auction of the FDA Unserviceable/Obsolete Plant, Property […]
Announcement || FDA System Maintenance
Please be informed that the Information and Communication Technology Management Division (ICTMD) will conduct a system maintenance activity from 29 October 2022, 7 AM to 02 November 2022, 7 AM. […]
FDA STATEMENT || On Diethylene glycol and Ethylene glycol – contaminated Cough and Cold Syrup Manufactured by Maiden Pharmaceuticals, Ltd.
All pharmaceutical products, especially cough and cold syrups, that use glycerine as solvent, diluent, and thickening agent, are mandatorily required to be tested for purity as raw materials when used. […]
Announcement || CDRR Cascading, Performance Review And Planning For Calendar Year 2022
Please be informed that the Center for Drug Regulation and Research (CDRR) will be having its Cascading, Performance Review and Planning for Calendar Year (CY) 2022 on 19-21 October 2022. […]
Announcement || FDA Academy Additional Training/Webinar Offering Schedule for the Month of November 2022
The Policy and Planning Service – FDA Academy would like to announce the additional training/seminar offering schedule for the month of November 2022 through online video-conferencing platform. Title of Training/Seminar […]
Announcement || All External Customers requesting Laboratory Testing from the Common Services Laboratory (CSL)
In line with the continuous improvement of the CSL systems and procedures, please be informed of the following implementation dates for the new Request for Analysis form, and its processes. […]
Announcement || WORK SUSPENSION
Due to Super Typhoon “Karding”, and in relation to the recommendation of the National Disaster Risk Reduction and Management Council (NDRRMC) to Malacañang and the approval of the President reflected […]